Daniel Wolfe

2.1k total citations
63 papers, 1.4k citations indexed

About

Daniel Wolfe is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel Wolfe has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 32 papers in Epidemiology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel Wolfe's work include Viral Infections and Outbreaks Research (16 papers), HIV, Drug Use, Sexual Risk (15 papers) and HIV/AIDS Research and Interventions (13 papers). Daniel Wolfe is often cited by papers focused on Viral Infections and Outbreaks Research (16 papers), HIV, Drug Use, Sexual Risk (15 papers) and HIV/AIDS Research and Interventions (13 papers). Daniel Wolfe collaborates with scholars based in United States, United Kingdom and Canada. Daniel Wolfe's co-authors include Patrizia Carrieri, Donald S. Shepard, Eric T. Harvill, Jonathan Cohen, Girish S. Kirimanjeswara, Michel D. Kazatchkine, Bradley Mathers, Kasia Malinowska-Sempruch, Chris Beyrer and Louisa Degenhardt and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Daniel Wolfe

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Wolfe United States 20 926 755 250 231 213 63 1.4k
Amy Matser Netherlands 19 626 0.7× 935 1.2× 148 0.6× 98 0.4× 186 0.9× 62 1.4k
Andrew J. Amato‐Gauci Sweden 24 837 0.9× 673 0.9× 292 1.2× 152 0.7× 193 0.9× 51 1.4k
Katy Sinka United Kingdom 18 737 0.8× 502 0.7× 214 0.9× 141 0.6× 106 0.5× 52 1.1k
Gregory S. Wallace United States 19 1.1k 1.2× 557 0.7× 161 0.6× 141 0.6× 56 0.3× 41 1.7k
Monika Naus Canada 24 1.4k 1.5× 545 0.7× 180 0.7× 161 0.7× 44 0.2× 88 2.0k
Chen Stein‐Zamir Israel 21 617 0.7× 408 0.5× 148 0.6× 176 0.8× 69 0.3× 70 1.5k
Preeti Pathela United States 24 810 0.9× 901 1.2× 724 2.9× 170 0.7× 318 1.5× 84 2.0k
Susan Hahné Netherlands 31 1.7k 1.9× 866 1.1× 212 0.8× 298 1.3× 50 0.2× 112 2.6k
Margaret Fearon Canada 25 898 1.0× 849 1.1× 64 0.3× 501 2.2× 76 0.4× 54 1.7k
Mary Shepherd United States 20 613 0.7× 642 0.9× 321 1.3× 171 0.7× 258 1.2× 34 1.4k

Countries citing papers authored by Daniel Wolfe

Since Specialization
Citations

This map shows the geographic impact of Daniel Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wolfe more than expected).

Fields of papers citing papers by Daniel Wolfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wolfe. The network helps show where Daniel Wolfe may publish in the future.

Co-authorship network of co-authors of Daniel Wolfe

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wolfe. A scholar is included among the top collaborators of Daniel Wolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wolfe. Daniel Wolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hofmeyer, Kimberly A., Christy L. Ventura, Kimberly L. Armstrong, et al.. (2024). Project NextGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future. Clinical Infectious Diseases. 79(1). 115–121. 6 indexed citations
3.
Martins, Karen & Daniel Wolfe. (2024). Marburg Virus Medical Countermeasures. Methods in molecular biology. 2877. 25–43.
5.
Knisely, Jane M., Rebecca Mandt, Shobana Balasingam, et al.. (2023). Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report. npj Vaccines. 8(1). 53–53. 56 indexed citations
6.
Carbonnelle, Caroline, Delphine Pannetier, Stéphane Mély, et al.. (2022). Natural History of Sudan ebolavirus to Support Medical Countermeasure Development. Vaccines. 10(6). 963–963. 11 indexed citations
7.
Wolfe, Daniel, Carol L. Sabourin, Michael Merchlinsky, et al.. (2021). Selection of Filovirus Isolates for Vaccine Development Programs. Vaccines. 9(9). 1045–1045. 5 indexed citations
8.
Wolfe, Daniel, et al.. (2021). Reprint of: Biotechnologies and the future of opioid addiction treatments. International Journal of Drug Policy. 94. 103273–103273. 2 indexed citations
9.
Wolfe, Daniel, Eric M. Espeland, Yonghong Gao, et al.. (2020). Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older. Vaccine. 38(50). 7970–7976. 8 indexed citations
10.
Wolfe, Daniel, et al.. (2018). Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Drug Safety. 41(10). 981–988. 19 indexed citations
11.
Wolfe, Daniel, et al.. (2015). Human rights and access to hepatitis C treatment for people who inject drugs. International Journal of Drug Policy. 26(11). 1072–1080. 43 indexed citations
12.
Challacombe, Jean F., Chris Stubben, Christopher P. Klimko, et al.. (2014). Interrogation of the Burkholderia pseudomallei Genome to Address Differential Virulence among Isolates. PLoS ONE. 9(12). e115951–e115951. 19 indexed citations
13.
Wolfe, Daniel, et al.. (2009). IL-10 Induction by Bordetella parapertussis Limits a Protective IFN-γ Response. The Journal of Immunology. 184(3). 1392–1400. 16 indexed citations
14.
Wolfe, Daniel, Anne M. Buboltz, & Eric T. Harvill. (2009). Inefficient Toll-Like Receptor-4 Stimulation Enables Bordetella parapertussis to Avoid Host Immunity. PLoS ONE. 4(1). e4280–e4280. 24 indexed citations
15.
Restif, Olivier, et al.. (2008). Of mice and men: asymmetric interactions betweenBordetellapathogen species. Parasitology. 135(13). 1517–1529. 14 indexed citations
16.
Cohen, Jonathan & Daniel Wolfe. (2008). Harm reduction and human rights: finding common cause. AIDS. 22(Suppl 2). S93–S94. 9 indexed citations
17.
Wolfe, Daniel, et al.. (2007). The O Antigen Enables Bordetella parapertussis To Avoid Bordetella pertussis -Induced Immunity. Infection and Immunity. 75(10). 4972–4979. 45 indexed citations
18.
Gopinathan, Lakshmi, et al.. (2007). Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes and Infection. 9(4). 442–448. 21 indexed citations
19.
Wolfe, Daniel, et al.. (2007). Delayed Role of Tumor Necrosis Factor–α in Overcoming the Effects of Pertussis Toxin. The Journal of Infectious Diseases. 196(8). 1228–1236. 14 indexed citations
20.
Wolfe, Daniel. (2007). Paradoxes in antiretroviral treatment for injecting drug users: Access, adherence and structural barriers in Asia and the former Soviet Union. International Journal of Drug Policy. 18(4). 246–254. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026